XML 78 R49.htm IDEA: XBRL DOCUMENT v3.22.0.1
Goodwill (Tables)
12 Months Ended
Dec. 31, 2021
Goodwill [Abstract]  
Goodwill - Goodwill [Text Block]

Philips Group

Goodwill

in millions EUR

 20202021
Balance as of January 1:  
Cost10,1829,094
Impairments(1,528)(1,080)
Book value8,6548,014
Changes in book value:  
Acquisitions1892,095
Impairments(144)(15)
Divestments and transfers to assets classified as held for sale(12)(189)
Translation differences and other(673)732
Balance as of December 31:  
Cost9,09411,793
Impairments(1,080)(1,156)
Book value8,01410,637
Goodwill - Goodwill allocated to the cash-generating units [Text Block]

Philips Group

Goodwill allocated to the cash-generating units

in millions of EUR

 20202021
Ambulatory Monitoring & Diagnostics1) 1,897
Hospital Patient Monitoring2)1,2461,663
Image-Guided Therapy2,6102,802
Sleep & Respiratory Care1,9152,031
Other (units carrying a non-significant goodwill balance)2,2442,245
Book value8,01410,637
1)Includes provisional goodwill related to the acquisition of BioTelemetry, see Acquisitions and divestments2)Previously named Monitoring & Analytics. Includes provisional goodwill related to the acquisition of Capsule Technologies, see Acquisitions and divestments
Goodwill - Key assumptions [Text Block]

Philips Group

Key assumptions 

2021

 compound sales growth rate1) 
 initial forecast periodextrapolation period2)used to calculate terminal value3)pre-tax discount rates
Ambulatory Monitoring & Diagnostics24.5%11.9%2.5%7.3%
Hospital Patient Monitoring4)5.4%3.4%2.5%7.8%
Image-Guided Therapy10.2%5.4%2.5%8.9%
Sleep & Respiratory Care9.2%5.0%2.5%9.2%
1)Compound sales growth rate is the annualized steady nominal growth rate over the forecast period 2)Also referred to later in the text as compound long-term sales growth rate3)The historical long-term growth rate is only applied to the first year after the 4 year extrapolation period, after which no further growth is assumed for the terminal value calculation4)Previously named Monitoring & Analytics.

Philips Group

Key assumptions 

2020

 compound sales growth rate1) 
 initial forecast periodextrapolation period2)used to calculate terminal value3)pre-tax discount rates
Hospital Patient Monitoring4)(0.3)%3.3%2.5%9.4%
Image-Guided Therapy8.6%4.9%2.5%9.0%
Sleep & Respiratory Care(1.2)%4.4%2.5%9.7%
1)Compound sales growth rate is the annualized steady nominal growth rate over the forecast period 2)Also referred to later in the text as compound long-term sales growth rate3)The historical long-term growth rate is only applied to the first year after the 4 year extrapolation period, after which no further growth is assumed for the terminal value calculation4)Previously named Monitoring & Analytics.